Home / Going-concern warnings / Bionano Genomics, Inc.
Filed 2026-03-23 · Form 10-K · Accession 0001411690-26-000007 nano
Price before filing: $1.15 (2026-03-20 close, split/dividend-adjusted)
Market cap at flag: $16.0M (2026-03-23) · Latest: $14.4M (2026-10-16)
| Window | BNGO | SPY | vs SPY | |
|---|---|---|---|---|
| 30 days | +8.7% | +9.7% | -1.0% | 2026-04-22 |
| 90 days | +0.0% | +15.1% | -15.1% | 2026-06-22 |
| 180 days | +59.1% | +19.9% | +39.3% | 2026-09-21 |
Return from the last close before the filing date to the first close on/after the window end. Pending windows have not fully elapsed. Past performance says nothing certain about the future.
"We cannot be certain that we will ever achieve or sustain profitability; • Our recurring losses, negative cash flows and significant accumulated deficit have raised substantial doubt regarding our ability to continue as a going concern."
Quoted from the filing. Source
The filing states that substantial doubt exists about the company's ability to continue as a going concern: it may not have enough cash to last the next 12 months. Expect dilution, debt deals or worse. An auditor's going-concern paragraph is the strongest form of this warning.
Source: management disclosure in Form 10-K (period 2025-12-31)
Read the original filing on SEC.gov →
Not investment advice. Automated summary; verify against the filing.
The week's most serious auditor changes, restatements, late filings and going-concern warnings, in plain English. Free. Unsubscribe anytime.
Newsletter delivered by beehiiv. See our privacy policy.